CONNEQT Health Limited (ASX:CQT)

Market Cap	17.38M -36.0%
Revenue (ttm)	5.80M +1.3%
Net Income	-17.21M
EPS	-0.04
Shares Out	643.53M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	876,398
Open	0.0270
Previous Close	0.0280
Day's Range	0.0270 - 0.0280
52-Week Range	0.0260 - 0.0640
Beta	0.62
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 11, 2026

About CONNEQT Health

CONNEQT Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disord...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CQT

Financial Performance

In fiscal year 2025, CONNEQT Health's revenue was 6.05 million, a decrease of -52.76% compared to the previous year's 12.81 million. Losses were -18.19 million, 168.9% more than in 2024.